COSMIC-312 Trial in HCC

obr has 860 videos Subscribe Here

Description: Daneng Li, MD, Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research, Liver Program Disease Team Lead, City of Hope explains the design of the COSMIC-312 study in hepatocellular carcinoma (HCC) and speculates the potential this trial has.
Shared By : obr
Posted on : 06/28/19
Added : 2 months ago
Category : Other